Olux (Clobetasol Propionate)

Clobetasol propionate is a high‑potency corticosteroid used to manage disorders of the skin that involve inflammation and excessive cell growth.

• Psoriasis: reduces scaling, redness and plaque thickness.
• Atopic dermatitis: alleviates itching and inflammation.
• Seborrheic dermatitis: controls flaking and erythema.
• Lichen planus: diminishes lesions and discomfort.
• Discrete plaque-type eczema: improves lesion appearance and symptom relief.

• Clobetasol propionate binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This action suppresses pro‑inflammatory cytokine production, decreases leukocyte migration, and induces vasoconstriction, resulting in marked anti‑inflammatory, antiproliferative and immunosuppressive effects in the skin.

Adverse reactions may appear locally at the application site or systemically after extensive use.

Common Side Effects

• Burning or stinging sensation at the site of application.
• Pruritus or mild itching.
• Dryness or flaking of the skin.
• Erythema or mild redness.
• Folliculitis or small pustules.
• Telangiectasia (visible small blood vessels).

Serious or Rare Side Effects

• Skin atrophy or thinning.
• Secondary bacterial, fungal or viral infection.
• Hypothalamic‑pituitary‑adrenal (HPA) axis suppression.
• Hypertrichosis (excessive hair growth).
• Contact dermatitis to formulation excipients.
• Systemic corticosteroid effects such as Cushingoid appearance.

Clobetasol propionate should be used according to medical guidance, with attention to duration, area treated and patient risk factors.

• Duration of therapy: limit to short courses, typically 2‑4 weeks, unless supervised.
• Application area: avoid large surface areas or occlusion unless directed.
• Age restrictions: use with caution in children and the elderly.
• Pre‑existing skin conditions: assess for infections before initiating therapy.
• Systemic absorption risk: monitor for signs of adrenal suppression with extensive use.
• Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Clobetasol propionate may interact with other topical agents or systemic drugs that influence corticosteroid metabolism or immune function.

Major Interactions (Avoid)

• Systemic corticosteroids: concurrent use can increase systemic glucocorticoid load.
• Potent CYP3A4 inhibitors (e.g., ketoconazole topical): may raise local drug levels.

Moderate Interactions (Monitor Closely):\n- Antifungal or antibacterial creams: risk of reduced efficacy or irritation.

• Skin‑lightening agents (hydroquinone): potential for increased irritation.
• Immunosuppressants (e.g., tacrolimus ointment): may alter local immune response.
• NSAID gels: combined irritation potential.
• Occlusive dressings: enhance absorption, requiring monitoring.